News

FDA Approves Wegovy to Treat Serious Liver Disease

The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated ...

NVO STOCK: Robbins LLP Reminds NVO Stockholders Of The Opportunity To Lead The Class Action Lawsuit Against Novo Nordisk A/S

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...